# A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer

> **NCT02787473** · PHASE2 · UNKNOWN · sponsor: **First People's Hospital of Hangzhou** · enrollment: 54 (estimated)

## Conditions studied

- Squamous Cell Lung Cancer

## Interventions

- **DRUG:** pemetrexed
- **DRUG:** cisplatin
- **RADIATION:** thoracic radiation therapy
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT02787473
- **Lead sponsor:** First People's Hospital of Hangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-10
- **Final completion:** 2020-09
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787473, "A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02787473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*